Invesco Ltd. Abbott Laboratories Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Abbott Laboratories stock. As of the latest transaction made, Invesco Ltd. holds 7,070,100 shares of ABT stock, worth $808 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

7,070,100

Previous 5,382,424 31.36%

Holding current value

$808 Million

Previous $559 Million 44.12%

% of portfolio

0.16%

Previous 0.12%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$100.07 - $118.13 $169 Million - $199 Million	1,687,676 Added 31.36%	7,070,100 $806 Million
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $68.5 Million - $76.5 Million	-680,245 Reduced 11.22%	5,382,424 $559 Million
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $7.92 Million - $8.75 Million	72,318 Added 1.21%	6,062,669 $689 Million
Q4 2023 Feb 12, 2024	BUY	$90.19 - $110.4 $3.67 Million - $4.49 Million	40,651 Added 0.68%	5,990,351 $659 Million
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $1.99 Million - $2.39 Million	20,851 Added 0.35%	5,949,700 $576 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $25.3 Million - $28.2 Million	-251,242 Reduced 4.07%	5,928,849 $646 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $35.4 Million - $41.7 Million	365,444 Added 6.28%	6,180,091 $626 Million
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $887,955 - $1.04 Million	9,341 Added 0.16%	5,814,647 $639 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $80.8 Million - $93.6 Million	835,363 Added 16.81%	5,805,306 $562 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $8.88 Million - $10.7 Million	-86,967 Reduced 1.72%	4,969,943 $540 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $75.1 Million - $91.6 Million	-659,073 Reduced 11.53%	5,056,910 $599 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $50.8 Million - $62.2 Million	439,875 Added 8.34%	5,715,983 $804 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $77.3 Million - $85.6 Million	-662,928 Reduced 11.16%	5,276,108 $623 Million
Q2 2021 Aug 17, 2021	SELL	$105.79 - $124.53 $16.8 Million - $19.7 Million	-158,540 Reduced 2.6%	5,939,036 $689 Million
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $66.9 Million - $78.8 Million	614,840 Added 11.21%	6,097,576 $731 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $20.6 Million - $22.5 Million	-196,499 Reduced 3.46%	5,482,736 $600 Million
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $493,664 - $599,519	5,387 Added 0.09%	5,679,235 $618 Million
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $51.7 Million - $66.2 Million	-675,262 Reduced 10.64%	5,673,848 $519 Million
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $52.5 Million - $76.8 Million	836,428 Added 15.17%	6,349,110 $501 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $72.6 Million - $80.8 Million	-924,421 Reduced 14.36%	5,512,682 $479 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $48.6 Million - $52.7 Million	-594,148 Reduced 8.45%	6,437,103 $539 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $112 Million - $130 Million	1,532,627 Added 27.87%	7,031,251 $591 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $75.6 Million - $91.4 Million	-1,141,137 Reduced 17.19%	5,498,624 $440 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $435 Million - $493 Million	6,639,761 New	6,639,761 $480 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account